AMAG - disclosed that a phase 3 study of its anemia treatment achieved primary endpoints. Buyers looked confident around 15.25 all the way up towards 16 an area you might want to eye for a long with a target area around 16.5+.
SQNM - stock moved higher even though they posted a Q4 that missed results. 15.5mil v. 15.8mil, so only 300k of a loss on revenue, but I'll be eying a short on this, these types of #'s dont constitute a 13% pop.
DECK - stern agee hit this stock late in the day and brought it tumbling down, will be eying pops to short into for further dissipation of shares. Put up awful e/r #'s a month ago too, super vague. I think its finally catching up to price action, justa side note.
APOL - love the trend thats setting up here, possible long, look for it to get up to 43 test, possible cross and push higher.